Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Deferiprone manufacturers

5 products found

Filters

5 products found

deferiprone

Tablets, film coated 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

deferiprone

Tablets, film coated 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
Turkey
Available for
Licensing with supply, Distribution only
Comments
Reference Product : Ferriprox
Manufacturer #2748
It is a privately held pharmaceutical company based in southeast Europe that was established in the 1990s to import and introduce pharmaceutical items into medicine. The company began by importing hemophilia and intensive care supplies, as well as immunoglobulin-containing items. To suit market demands, the company has added additional dermatological, cardiological, urological, and surgical goods to its portfolio since then. They now offer a diverse product line that includes not only prescription but also OTC, medical gadgets, and dermo-cosmetics.

Manufacturer usually replies in 7 days

deferiprone

Tablets, film coated 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
WHO
Unavailable markets
Philippines
Manufacturer #559

Manufacturer usually replies in 8 days

deferiprone

Capsules 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, PICS, Malaysia, Russia
Manufacturer #20862

Manufacturer usually replies in 14 days

deferiprone

Oral suspension 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801

Manufacturer usually replies in 11 days

Deferiprone is an iron chelator medication used to treat thalassemia major. Suppliers of deferiprone market it in the form of 500mg and 1000mg oral tablets. The developer and earliest manufacturer of deferiprone is Apotex Pharmaceuticals, which first introduced the drug into the market in 1994. It is currently approved in over 60 countries worldwide, including but not limited to China, Australia, the U.S., and across Europe. Apotex remains the largest manufacturer and supplier of deferiprone medications globally. Retail prices per 100 (500mg) tablets of deferiprone are typically around 300 EUR.